Rilonacept

Unassigned

New Medicines

Recurrent symptomatic pericarditis

Information

New molecular entity
Kiniksa
Kiniksa

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Recombinant fusion protein that blocks IL-1α and IL-1β signaling
Recurrent pericarditis has a number of causes, including infective inflammatory and metabolic [2].
Recurrent symptomatic pericarditis
Subcutaneous injection